Analysis of hemorrhage upon ultrasound-guided percutaneous renal biopsy in China: a retrospective study

Fang-Fang Li1, Yu-Xia Guan2, Tong-Xin Li3

  • 1Department of Endocrinology, Peking Union Medical College Hospital, Peking, China.

PubMed

Insights

Ultrasound-guided renal biopsy has a 37.70% hemorrhage risk, influenced by patient factors like sex, BMI, and pre-biopsy platelets. Careful perioperative management and fluid monitoring are crucial for reducing complications.

Area of Science:

  • Nephrology
  • Radiology
  • Clinical Medicine

Background:

  • Ultrasound-guided percutaneous renal biopsy (PRB) is a gold standard for chronic kidney disease (CKD) diagnosis.
  • Post-biopsy hemorrhage is a common complication, with severe cases potentially leading to nephrectomy or death.
  • Minimizing complications while ensuring biopsy success remains a key clinical research area.

Purpose of the Study:

  • To identify risk factors associated with post-biopsy hemorrhage after ultrasound-guided PRB.
  • To analyze the incidence of hemorrhagic complications and related patient characteristics.
  • To inform improved perioperative management strategies for renal biopsy procedures.

Main Methods:

  • Retrospective analysis of a renal biopsy database.
  • Inclusion of 1146 patients undergoing ultrasound-guided PRB from September 2017 to December 2020.
  • Statistical analysis using SPSS software to evaluate complication risk factors.

Main Results:

  • The overall post-biopsy hemorrhage rate was 37.70%.
  • Risk factors for hemorrhage included female sex, lower BMI, lower pre-biopsy platelet count, prolonged APTT, higher albumin levels, and postoperative urination within 4 hours.
  • No deaths were reported; minor bleeding occurred in 29.41% and major bleeding in 0.96% of patients.

Conclusions:

  • The incidence of post-biopsy bleeding is significant and linked to specific patient and procedural factors.
  • Highlights the importance of comprehensive risk assessment and tailored perioperative care.
  • Emphasizes the need for vigilant fluid management post-ultrasound-guided PRB to mitigate bleeding risks.
Abstract